The C-Terminal Putative Nuclear Localization Sequence of BReast cancer Metastasis Suppressor 1, BRMS1, Is Necessary for Metastasis Suppression

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Hurst, Douglas R ^a,b   Xie, Yi ^a   Thomas, John W ^a   Liu, Jianzhong ^a   Edmonds, Mick D ^a   Stewart, Mark D ^a   Welch, Danny R ^c  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER METASTASIS SUPPRESSOR 1; MICRORNA 10B; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR SIN3A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; HAPLORHINI; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; METASTASIS INHIBITION; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; MICRORNAS; MUTATION; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NUCLEAR LOCALIZATION SIGNALS; NUCLEAR PROTEINS; PROTEIN BINDING; REPRESSOR PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84873486251     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055966     Document Type: Article

References (49)

1. Seraj MJ, Samant RS, Verderame MF, Welch DR, (2000) Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res 60: 2764-2769.
2. Champine PJ, Michaelson J, Weimer B, Welch DR, DeWald DB, (2007) Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression. Clin Exp Metastasis 24: 551-565.
3. Cicek M, Samant RS, Kinter M, Welch DR, Casey G, (2004) Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells. Clin Exp Metastasis 21: 149-157.
4. Edmonds MD, Hurst DR, Vaidya KS, Stafford LJ, Chen D, et al. (2009) Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression. Int J Cancer 125: 1778-1785.
5. Rivera J, Megias D, Bravo J, (2007) Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1. J Proteome Res 6: 4006-4018.
6. Hurst DR, Welch DR, (2011) Metastasis suppressor genes: at the interface between the environment and tumor cell growth. Int Rev Cell Mol Biol 286: 107-180.
7. Eccles SA, Welch DR, (2007) Metastasis: recent discoveries and novel treatment strategies. Lancet 369: 1742-1757.
8. Langley RR, Fidler IJ, (2007) Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocrine Rev 28: 297-321.
9. Nguyen DX, Massague J, (2007) Genetic determinants of cancer metastasis. Nature Rev Genet 8: 341-352.
10. Hurst DR, Welch DR, (2011) Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppression. FEBS Lett 585: 3185-3190.
11. Hurst DR, Xie Y, Vaidya KS, Mehta A, Moore BP, et al. (2008) Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells. J Biol Chem 283: 7438-7444.
12. Meehan WJ, Samant RS, Hopper JE, Carrozza MJ, Shevde LA, et al. (2004) Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J Biol Chem 279: 1562-1569.
13. Hurst DR, (2012) Metastasis suppression by BRMS1 associated with SIN3 chromatin remodeling complexes. Cancer Metastasis Rev. 31: 641-651.
14. Nikolaev AY, Papanikolaou NA, Li M, Qin J, Gu W, (2004) Identification of a novel BRMS1-homologue protein p40 as a component of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex. Biochem Biophys Res Commun 323: 1216-1222.
15. Doyon Y, Cayrou C, Ullah M, Landry AJ, Cote V, et al. (2006) ING Tumor Suppressor Proteins Are Critical Regulators of Chromatin Acetylation Required for Genome Expression and Perpetuation. Molec Cell 21: 51-64.
16. Le Guezennec X, Vermeulen M, Stunnenberg HG, (2006) Molecular characterization of Sin3 PAH-domain interactor specificity and identification of PAH partners. Nucleic Acids Res 34: 3929-3937.
17. Smith KT, Martin-Brown SA, Florens L, Washburn MP, Workman JL, (2010) Deacetylase inhibitors dissociate the histone-targeting ING2 subunit from the Sin3 complex. Chem Biol 17: 65-74.
18. Bantscheff M, Hopf C, Savitski MM, Dittmann A, Grandi P, et al. (2011) Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat Biotechnol 29: 255-265.
19. Shiio Y, Rose DW, Aur R, Donohoe S, Aebersold R, et al. (2006) Identification and characterization of SAP25, a novel component of the mSin3 corepressor complex. Mol Cell Biol 26: 1386-1397.
20. McDonel P, Demmers J, Tan DW, Watt F, Hendrich BD, (2011) Sin3a is essential for the genome integrity and viability of pluripotent cells. Dev Biol 363: 62-73.
21. Bodenstine TM, Vaidya KS, Ismail A, Beck BH, Cook LM, et al. (2010) Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition. Cancer Res 70: 10002-10011.
22. Kapoor P, Saunders MM, Li Z, Zhou Z, Schaeffer N, et al. (2004) Breast cancer metastatic potential: Correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. Int J Cancer 111: 693-697.
23. Saunders MM, Seraj MJ, Li ZY, Zhou ZY, Winter CR, et al. (2001) Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res 61: 1765-1767.
24. DeWald DB, Torabinejad J, Samant RS, Johnston D, Erin N, et al. (2005) Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. Cancer Res 65: 713-717.
25. Vaidya KS, Harihar S, Stafford LJ, Hurst DR, Hicks DG, et al. (2008) Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling. J Biol Chem 283: 28354-28360.
26. Cicek M, Fukuyama R, Welch DR, Sizemore N, Casey G, (2005) Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-κB activity. Cancer Res 65: 3586-3595.
27. Cicek M, Fukuyama R, Cicek MS, Sizemore S, Welch DR, et al. (2009) BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter. Clin Exp Metastasis 26: 229-237.
28. Liu Y, Smith PW, Jones DR, (2006) Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Molec Cell Biol 26: 8683-8696.
29. Samant RS, Clark DW, Fillmore RA, Cicek M, Metge BJ, et al. (2007) Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation. Mol Cancer 6: 6.
30. Samant RS, Seraj MJ, Saunders MM, Sakamaki T, Shevde LA, et al. (2001) Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin Exp Metastasis 18: 683-693.
31. Shevde LA, Samant RS, Goldberg SF, Sikaneta T, Alessandrini A, et al. (2002) Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp Cell Res 273: 229-239.
32. Zhang S, Lin QD, Di W, (2006) Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Int J Gynecol Cancer 16: 522-531.
33. Phadke PA, Vaidya KS, Nash KT, Hurst DR, Welch DR, (2008) BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. Am J Pathol 172: 809-817.
34. Rivera J, Megias D, Navas C, Bravo J, (2009) Identification of essential sequences for cellular localization in BRMS1 metastasis suppressor. PLoS One 4: e6433.
35. Rivera J, Megias D, Bravo J, (2010) Sorting nexin 6 interacts with breast cancer metastasis suppressor-1 and promotes transcriptional repression. J Cell Biochem 111: 1464-1472.
36. Slipicevic A, Holm R, Emilsen E, Ree Rosnes AK, Welch DR, et al. (2012) Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival. BMC Cancer 12: 73.
37. Hurst DR, Mehta A, Moore BP, Phadke PA, Meehan WJ, et al. (2006) Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone. Biochem Biophys Res Comm 348: 1429-1435.
38. Hurst DR, Xie Y, Edmonds MD, Welch DR, (2009) Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model. Clin Exp Metastasis 26: 89-96.
39. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, et al. (2009) Breast cancer metastasis suppressor 1 BRMS1 up-regulates miR-146 that suppresses breast cancer metastasis. Cancer Res 69: 1279-1283.
40. Frolova N, Edmonds MD, Bodenstine TM, Seitz R, Johnson MR, et al. (2009) A Shift from Nuclear to Cytoplasmic Breast Cancer Metastasis Suppressor 1 Expression Is Associated with Highly Proliferative Estrogen Receptor-Negative Breast Cancers. Tumour Biol 30: 148-159.
41. Al-Alwan M, Olabi S, Ghebeh H, Barhoush E, Tulbah A, et al. (2011) Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules. PLoS One 6: e27339.
42. Riker AI, Samant RS, (2012) Location, location, location: The BRMS1 protein and melanoma progression. BMC Med 10: 19.
43. Cook LM, Cao X, Dowell AE, Debies MT, Edmonds MD, et al. (2012) Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis. Clin Exp Metastasis 29: 315-325.
44. Welch DR, (1997) Technical considerations for studying cancer metastasis in vivo. Clin Exp Metastasis 15: 272-306.
45. Silveira AC, Hurst DR, Vaidya KS, Ayer DE, Welch DR, (2008) Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells. Cancer Lett 276: 32-37.
46. Silverstein RA, Ekwall K, (2005) Sin3: a flexible regulator of global gene expression and genome stability. Curr Genet 47: 1-17.
47. Grzenda A, Lomberk G, Zhang JS, Urrutia R, (2009) Sin3: Master scaffold and transcriptional corepressor. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms 1789: 443-450.
48. Edmonds MD, Hurst DR, Welch DR, (2009) Linking metastasis suppression with metastamiR regulation. Cell Cycle 8: 2673-2675.
49. Hurst DR, Edmonds MD, Welch DR, (2009) Metastamir: The field of metastasis-regulatory microRNA is spreading. Cancer Res 69: 7495-7498.